Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 61 | 57 | 53 | 36 | 30 |
| Gross Profit | 61 | 57 | 53 | 36 | 30 |
| Operating Expenses | 634 | 592 | 704 | 796 | 1,155 |
| Operating Income | -573 | -535 | -651 | -760 | -1,125 |
| Interest Expense | 215 | 172 | 183 | 102 | 0 |
| Other Income | 5 | 0 | 109 | 0 | 5 |
| Pre-tax Income | -783 | -706 | -726 | -861 | -1,120 |
| Net Income Continuous | -783 | -706 | -726 | -861 | -1,120 |
| Net Income | $-783 | $-706 | $-726 | $-861 | $-1,120 |
| EPS Basic Total Ops | -0.07 | -0.06 | -0.05 | -0.07 | -0.10 |
| EPS Basic Continuous Ops | -0.07 | -0.06 | -0.05 | -0.07 | -0.10 |
| EPS Diluted Total Ops | -0.07 | -0.06 | -0.05 | -0.07 | -0.10 |
| EPS Diluted Continuous Ops | -0.07 | -0.06 | -0.05 | -0.07 | -0.10 |
| EBITDA(a) | $-453 | $-424 | $-550 | $-601 | $-1,109 |